BML Capital Management LLC bought a new position in shares of Seer, Inc. (NASDAQ:SEER – Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 2,186,587 shares of the company’s stock, valued at approximately $4,876,000. Seer comprises approximately 2.6% of BML Capital Management LLC’s investment portfolio, making the stock its 10th largest holding. BML Capital Management LLC owned approximately 3.95% of Seer as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in SEER. Marquette Asset Management LLC purchased a new stake in Seer in the second quarter valued at $103,000. Covestor Ltd purchased a new position in shares of Seer during the 3rd quarter valued at about $109,000. Corient Private Wealth LP raised its stake in shares of Seer by 15.8% during the 2nd quarter. Corient Private Wealth LP now owns 73,200 shares of the company’s stock valued at $122,000 after buying an additional 10,000 shares during the last quarter. NewEdge Advisors LLC purchased a new position in shares of Seer during the 1st quarter valued at about $132,000. Finally, Rangeley Capital LLC lifted its holdings in shares of Seer by 821.5% in the 1st quarter. Rangeley Capital LLC now owns 184,302 shares of the company’s stock valued at $310,000 after buying an additional 164,302 shares during the period. 75.20% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
Separately, Weiss Ratings restated a “sell (d-)” rating on shares of Seer in a research note on Thursday, October 15th. Two research analysts have rated the stock with a Strong Buy rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Buy” and a consensus price target of $4.00.
Check Out Our Latest Analysis on Seer
Seer Trading Down 1.3%
NASDAQ SEER opened at $1.57 on Friday. The stock has a market capitalization of $86.93 million, a price-to-earnings ratio of -1.37 and a beta of 1.49. Seer, Inc. has a twelve month low of $1.53 and a twelve month high of $2.38. The stock has a 50-day moving average of $1.94 and a 200 day moving average of $1.91.
Seer (NASDAQ:SEER – Get Free Report) last issued its quarterly earnings data on Tuesday, November 10th. The company reported ($0.25) EPS for the quarter, beating the consensus estimate of ($0.26) by $0.01. The company had revenue of $3.98 million for the quarter, compared to analyst estimates of $4.15 million. Seer had a negative return on equity of 27.03% and a negative net margin of 450.86%.
About Seer
Seer, Inc. is a life sciences company that develops tools for large-scale protein analysis, or proteomics. Founded in 2017 and based in Redwood City, California, the company serves researchers studying biology and disease. Its main offering, the Proteograph Product Suite, uses engineered nanoparticles to capture a broad range of proteins from biological samples. The suite combines nanoparticle reagents, consumables, automation and software with mass spectrometry workflows to help researchers analyze complex samples.
Recommended Stories
- Five stocks we like better than Seer
- Nu Holdings Earnings Show a Compounder Priced Like a Brazil Bet
- Game On: The Hidden Value in Take-Two’s Stock
- LightPath Technologies’ Record Backlog Highlights a Bigger Defense Opportunity
- A 10-Stock Strategy That Balances AI Growth With Cash Flow
Receive News & Ratings for Seer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Seer and related companies with MarketBeat.com's FREE daily email newsletter.
